bioAffinity Technologies (BIAF) Retained Earnings (2021 - 2026)
bioAffinity Technologies has reported Retained Earnings over the past 6 years, most recently at -$72.2 million for Q1 2026.
- Quarterly Retained Earnings fell 28.23% to -$72.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$72.2 million through Mar 2026, down 28.23% year-over-year, with the annual reading at -$68.6 million for FY2025, 27.79% down from the prior year.
- Retained Earnings was -$72.2 million for Q1 2026 at bioAffinity Technologies, down from -$68.6 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$35.0 million in Q3 2022 and troughed at -$72.2 million in Q1 2026.
- The 5-year median for Retained Earnings is -$48.7 million (2024), against an average of -$50.6 million.
- Year-over-year, Retained Earnings dropped 20.05% in 2024 and then fell 28.99% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$36.7 million in 2022, then decreased by 21.65% to -$44.6 million in 2023, then fell by 20.27% to -$53.6 million in 2024, then decreased by 27.79% to -$68.6 million in 2025, then dropped by 5.32% to -$72.2 million in 2026.
- Per Business Quant, the three most recent readings for BIAF's Retained Earnings are -$72.2 million (Q1 2026), -$68.6 million (Q4 2025), and -$65.4 million (Q3 2025).